Lexicon Pharmaceuticals (LXRX) PT Lowered to $25 at Stifel; 'Despite Slow Xermelo Progress, We Still Can’t Reconcile Valuation Here'
Tweet Send to a Friend
Stifel lowered its price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
